FIELD: medicine; pharmacology.
SUBSTANCE: invention refers to chemical-pharmaceutical industry, medicine, pharmacology and concerns the production of antimignetic agents. Pharmaceutical composition, which is a solid dosage form presented in the form of tablets, has antiserotonin action and can be used as antimigraine agent. Pharmacological action is associated with elimination of serotonin effects in the basin of the middle cerebral artery. Tablets containing 9-diethylaminoethyl-2-(4-methoxyphenyl) imidazo[1,2-a]benzimidazole dihydrochloride substance as an active ingredient are obtained by pressing with ludopress and magnesium stearate, comply with the requirements of the State Pharmacopeia of the Russian Federation XIV edition.
EFFECT: what is presented is a pharmaceutical composition of antimigraine action in solid dosage form in the form of tablets.
1 cl, 2 dwg, 7 tbl
Title | Year | Author | Number |
---|---|---|---|
MEDICATIONS EXHIBITING PROPERTIES OF ANTAGONISTS OF SEROTONIN 5-HT- RECEPTORS | 2011 |
|
RU2465901C2 |
PHARMACEUTICAL COMPOSITION IN SOLID FORM WITH ANALGESIC ACTIVITY | 2013 |
|
RU2545861C1 |
PHARMACEUTICAL COMPOSITION WITH ANTIMIGRAINE ACTION (VERSIONS) | 2008 |
|
RU2424803C2 |
PHARMACEUTICAL COMPOSITION PREVENTING DEVELOPMENT OF PREEXCITATION SYNDROME | 2011 |
|
RU2453313C1 |
2-(3,4-DIHYDROXYPHENYL)-9-DIETHYLAMINOETHYLIMIDAZO[1,2-a]BENZIMIDAZOLE DIHYDROBROMIDE AND BASED ON IT PHARMACEUTICAL COMPOSITION | 2008 |
|
RU2391979C2 |
AGENT SHOWING SEROTONIN 5-HT-RECEPTOR ANTAGONIST PROPERTIES | 2010 |
|
RU2438669C1 |
HAEMORHEOLOGIC AGENT CAPABLE OF REDUCING INSULING RESISTANCE AND RESTORING BODY TOLERANCE TO GLUCOSE AND PHARMACEUTICAL COMPOSITION BASED ON SAID AGENT | 2007 |
|
RU2386634C2 |
9-(2-DIETHYLAMINOETHYL)-2-PHENYLIMIDAZO[1,2-a]BENZIMIDAZOLE HYDROBROMIDE ELICITING PROPERTY OF SEROTONIN 5-HT-RECEPTOR ANTAGONIST | 2005 |
|
RU2285006C1 |
PHARMACEUTICAL COMPOSITION WITH ANALGESIC ACTIVITY IN INJECTION FORM (VERSIONS) | 2013 |
|
RU2563211C2 |
PHARMACEUTICAL COMPOSITION OF ANTITHROMBOTIC ACTION IN SOLID DOSAGE FORM IN THE FORM OF TABLETS | 2019 |
|
RU2696869C1 |
Authors
Dates
2019-08-07—Published
2019-03-05—Filed